Search results
Results From The WOW.Com Content Network
Centers for Dialysis Care; Concerto Renal Services; DaVita Inc. Diversified Specialty Institute Holdings, Inc. Dialysis Clinic, Inc; Evergreen Nephrology; Fresenius Medical Care; Holy Cross Renal Center; Legacy Dialysis; Liberty Home Dialysis; National Renal Care; Northwest Kidney Centers; Olympus Dialysis [https://www.premierdialysismi.com ...
Gambro opened its first dialysis clinic in Lund in 1991. The clinic activities expanded under the name Gambro Healthcare and by 2005 the company managed 150 dialysis clinics worldwide. Gambro Healthcare was divested from Gambro in 2007 and taken over by Bridgepoint Capital, a major private healthcare investor in Europe, and the company ...
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [ clarify ] , and other extracorporeal therapies for chronic and acute patients.
For premium support please call: 800-290-4726 more ways to reach us
OSU writes that the first osteopathic hospital in Tulsa was opened in 1924 at 14th and Peoria Ave. by C. D. Heasley, who named it the Tulsa Clinic Hospital. Three years later, Healey moved the facility to a 25-bed converted apartment building at 1321 South Peoria. The hospital was later sold and renamed Byrne Memorial Hospital. [3]
Dialysis Clinic, Inc. is a nonprofit medical corporation founded in 1971 and chartered as a 501(c)(3) tax-exempt organization under IRS regulations. It was founded for care and research of patients with kidney disease and supports activities in kidney transplant and dialysis across the US.
A liver support system or diachysis is a type of therapeutic device to assist in performing the functions of the liver. Such systems focus either on removing the accumulating toxins (liver dialysis), or providing additional replacement of the metabolic functions of the liver through the inclusion of hepatocytes to the device (bioartificial liver device).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. [3] The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.